Possible association between ocular chloramphenicol and aplastic anaemia - The absolute risk is very low

British Journal of Clinical Pharmacology

Volumn 46, Issue 2, 1998, Pages 181-184

  Laporte, Joan Ramon ^a,b   Vidal, Xavier ^a   Ballarín, Elena ^a   Ibáñez, Luisa ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Aplastic anaemia; Chloramphenicol; Ocular

Indexed keywords

AUROTHIOMALATE; CHLORAMPHENICOL; COTRIMOXAZOLE; EYE DROPS; PHENYLBUTAZONE; SULFACETAMIDE; TRIETHYLPERAZINE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CLINICAL TRIAL; EYE DISEASE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANEMIA, APLASTIC; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHLORAMPHENICOL; FEMALE; HUMANS; MALE; PROTEIN SYNTHESIS INHIBITORS; RISK; SPAIN;

EID: 0031825541     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00773.x     Document Type: Article

References (25)

1. Doona M, Waise JB. Use of chloramphenicol as topical eye medication: time to cry halt? Br Med J 1995; 310: 1217-1218.
2. Mulla RJ, Barnes E, Rogers TR. Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases. Br Med J 1995; 311: 450.
3. Buckley RJK, Kirkness CM, Kanski JJ, Ridgway AEA, Tullo AB, Watson PG. Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasia. Br Med J 1995; 311: 450.
4. Hall AV, Das SS, Tabaqchali S. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses. Br Med J 1995; 311: 450-451.
5. Rayner SA, Buckley RJ. Ocular chloramphenicol and aplastic anaemia. Is there a link? Drug Safety 1996; 14: 273-276.
6. McGhee CNJ, Anastas CN. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia? Br J Ophthalmol 1996; 80: 182-184.
7. Rosenthal RL, Blackman A. Bone-marrow hypoplasia following use of chloramphenicol eye drops. JAMA 1965; 191: 148-149.
8. Carpenter G. Chloramphenicol eye-drops and marrow aplasia. Lancet 1975; 2: 326.
9. Abrams SM, Degnan TJ, Vinciguerra V. Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 1980; 140: 576-577.
10. Fraunfelder FT, Bagby GC, Kelly DJ. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982; 93: 356-360.
11. Polak BCP. Chlooramfenical in de oogheelkunde. Geneesmiddelenbulletin 1984; 18: 31-33.
12. Issaragrisil S, Piankijagum A. Aplastic anemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature. J Med Ass Thailand 1985; 68: 309-312.
13. Elberg JJ, Hansen WH. Kloramfenikoløjendråber og aplastisk anaemi. Ugeskr Laeger 1986; 148: 2227-2228.
14. Fernández de Sevilla T, Alegre J, Vallespí T, Falcó V, Martínez-Vázquez JM. Adult pure red cell aplasia following topical ocular chloramphenicol. Br J Ophthalmol 1990; 74: 640.
15. Brodsky E, Biger Y, Zfidan Z, Schneider M. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Israel J Med Sci 1989; 25: 54.
16. McWhae JA, Chang J, Lipton JH. Drug-induced fatal aplastic anemia following cataract surgery. Can J Ophthalmol 1992; 27: 313-315.
17. Flegg P, Cheong I. Welsby PD. Chloramphenicol. Are concerns about aplastic anaemia justified? Drug Safety 1992; 7: 167-169.
18. International Agranulocytosis and Aplastic Anemia Study. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 1983; 24: 833-836.
19. Laporte JR, Capellà D, Juan J. Agranulocytosis induced by cinepazide. Eur J Clin Pharmacol 1990; 38: 387-388.
20. Ibáñez L, Juan J, Pérez E, Carné X, Laporte JR. Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach, Eur Heart J 1991; 12: 639-641.
21. Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press, 1991.
22. Keisu M, Wiholm B-E., Öst A, Mortimer O. Acetazolamide-associated aplastic anaemia. J Intern Med 1990; 228: 627-632.
23. Wiholm B-E, Kelly JP, Kaufman D, Issaragrisil S, Levy M, Anderson T, Shapiro S. Does use of ocular chloramphenicol cause aplastic anaemia? Br Med J 1998; 316: 666.
24. Yunis AA. Chloramphenicol. Relation of structure to activity and toxicity. Ann Rev Pharmacol Toxicol 1988; 28: 83-100.
25. Scruggs J, Wallace T, Hanna C. Route of absorption of drug and ointment after application to the eye. Ann Ophthalmol 1978; 10: 267-271.